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The binding of [LZSI]triiodothyronine (T,) to freshly prepared rat hepatocytes was studied at 0” C. The abun- 
dant non-saturable binding could be suppressed by washing the cells with alkaline buffer, pH 10.5 at O’C, 
without loss of cell viability, thus allowing detection of saturable binding. Three classes of binding sites were 
identified from analysis of the saturable T, binding in the presence and absence of bromosulfophthalein 
(BSP). One of these classes was inhibited by BSP. The T, dissociation constants were 3.5, 35 and 115 nM 
and the number of sites was respectively 0.9, 20 and 36 x IO6 sites/cell. L-T, had a lo-times higher affinity 
than D-T, and a 50-times higher affinity than triiodothyroacetic acid. Saturable T, binding was associated 
with plasma membrane-containing subcellular fractions. These binding sites may be related to those pre- 
viously described in isolated plasma membranes from rat liver and could be involved in the entry of T, 
into the hepatocyte. 
Triiodothyronine Thyroid hormone receptor Ceil membrane binding site Thyroid hormone action 
BromosulJbphthalein 
1. INTRODUCTION 
Although thyroid hormones are thought to exert 
their effects at more than one initial locus, the cell 
nucleus is considered to be the main site of action, 
where triiodothyronine (Ts) influences gene expres- 
sion (review [l]). 
In the liver, intranuclear T3 has a plasma origin 
[2]. The translocation from plasma to the in- 
tracellular compartment was at first presumed to 
take place by passive diffusion. However, active 
transport into isolated rat liver cells was described 
[3,4] and recently, receptor-mediated endocytosis 
of T3 was reported to occur in GHs cells and mouse 
fibroblasts [5,6]. 
Specific T3-binding sites have been detected in 
purified rat liver plasma membrane [7,8] and were 
suggested to be implicated in the cellular entry of 
T3. 
The aim of the present work was to identify 
saturable T3 binding to unfractionated isolated 
(Isolated hepatocyte) 
hepatocytes at O”C, since thyroid hormones were 
reported not to be internalized at low temperature 
[6,9,10]. Such binding sites would presumably be 
located at the cell surface and their identification 
and characterization is a prerequisite for the study 
of their function and regulation in intact cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
3,3,5’-Triiodo-L-thyronine (L-T3), 3,3’,5-tri- 
iodo-D-thyronine (D-T3), L-thyroxine (Td), 
3,3’,5-triiodothyroacetic acid (triac), 3,5-diiodo- 
L-thyronine (Tz), DL-thyronine (To), bovine serum 
albumin (type V) (BSA), collagenase (type I), soy- 
bean trypsin inhibitor and bromosulfophthalein 
(BSP) were purchased from Sigma; 3,3’ ,5’-tri- 
iodo-L-thyronine (r-T3) from Calbiochem; Hepes 
from Boehringer; Eagle’s basal medium from Gib- 
co; Percoll from Pharmacia; Dowex (AGlX8) 
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from Bio-Rad; [lz51]T3 (spec. act. >44 MBq/pg) 
from Amersham. 
All polystyrene tubes and pipet tips, used for 
handling thyroid hormones, were siliconized 
(Sigmacote, Sigma). 
2.2. Methods 
Male Wistar rats (-200 g body wt) were 
thyroidectomized and, 4-10 weeks later, 
hepatocytes were isolated by the collagenase perfu- 
sion method of Seglen [l l] modified by Oldberg et 
al. [12]. Cells were incubated in oxygenated 
medium A (Eagle’s basal medium supplemented 
with 2.6 g/l glucose and 10 mM Hepes, pH 7.4) 
for 30 min at 37”C, centrifuged (70 x g, 2 min) 
and resuspended in isotonic Percoll diluted with 
medium A (d = 1.09). After centrifugation at 400 
x g for 5 min, the pellet of viable cells was 
resuspended in medium A and kept at 0°C. 
Viability was determined by the trypan blue ex- 
clusion test. It was over 97% after purification 
through Percoll and was maintained for at least 
4 h at 0°C. 
Unless otherwise stated, standard conditions for 
measurement of binding were as follows: 4 x lo5 
hepatocytes uspended in 1 ml medium A were in- 
cubated with [iz51]T3 and other additives in 
siliconized polystyrene tubes for 4 h at 0°C. 
Incubation was terminated by addition of 10 pM 
unlabelled TX and centrifugation at 70 x g for 
2 min. Unbound T3 was determined on an aliquot 
of the supernatant. The cell pellet was washed by 
successive resuspension/centrifugation (70 x g, 
2 min), once with 1.5 ml glycine buffer (50 mM 
glycine, 150 mM NaCl, 3% (w/v) BSA, pH 10.5) 
and twice with 2 ml Hepes buffer (137 mM NaCl, 
4.7 mM KCl, 0.65 mM MgS04, 1.2 mM CaC12, 
8.5 mM Hepes, pH 7.4). These buffers contained 
10pM unlabelled T3 and all operations were per- 
formed at 0-4°C. Bound radioactivity was 
measured on cell pellets with an efficiency of 80%. 
Saturable binding was obtained by subtraction of 
the binding measured in the presence of 10pM 
unlabelled T3 from those measured in its absence. 
3. RESULTS AND DISCUSSION 
3.1. Evidence for saturable binding of T3 to 
isolated hepatocytes at 0°C 
In preliminary experiments, hepatocytes (2 x lo6 
42 
cells/ml) were incubated with 0.1 nM [‘251]T3 f
1 PM unlabelled T3 at 0°C and bound radioactivity 
was measured by a rapid oil centrifugation techni- 
que as in [6]. No saturable binding was observed: 
indeed, bound radioactivity in the presence of 
unlabelled T3 was 20-30% higher than in its 
absence, irrespective of the incubation time (rang- 
ing from 1 to 90 min) (not shown). Similar absence 
of saturability of [1251]T3 uptake by hepatocyte was 
recently reported [ 131, when measured by an oil 
centrifugation technique. 
To improve the procedure for separation of 
bound and unbound T3, cells were washed by suc- 
cessive centrifugations/resuspensions ( ee section 
2). Since the solubility of iodothyronines increases 
at extreme pH, the effect of the washing buffer pH 
on the binding of T3 to isolated cells was examined. 
Contrary to the results obtained with the oil cen- 
trifugation technique, specific binding was detec- 
table at pH 7.4. In addition, fig.lA shows that, 
when the pH of the first washing buffer was in- 
creased, the amount of non-saturable binding 
decreased markedly from -70% of total binding at 
pH 7.5 to less than 10% at pH 11. Consequently, 
the differential saturable binding increased and 
reached a plateau at pH -10. 
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Fig. 1. Effect of pH of washing buffer on binding of Ts 
to hepatocytes. 2 x lo6 cells/ml were incubated with 
0.1 nM [‘Z51]Ts, in the absence (total binding) or 
presence (non-saturable binding) of 10 pM unlabelled 
T3, for 2 h at 0°C. Cells were washed by successive 
centrifugations/resuspensions (see section 2), once with 
1.5 ml buffer at various pH values (Hepes buffer, pH 
7.5; 150 mM NaCl/lO mM Tris buffer, pH 8.5; glycine 
buffer, pH 9.5-l 1.5), without (A) or with (B) 3% (w/v) 
BSA, and twice with 2 ml Hepes buffer, pH 7.4. Each 
point is the mean of triplicates (coefficient of variation 
<2.5%). Saturable binding was calculated as the 
difference between total and non-saturable binding. 
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Cell viability was not affected by the contact 
with alkaline buffer (up to pH 11) provided the 
cells were processed at a temperature close to 0°C. 
The addition of 3% (w/v) BSA to the washing 
buffer increased the amount of saturable binding 
measured by 20-40% (fig. 1B). The effect was par- 
ticularly noticeable when the pH was close to 
neutrality. Increasing the concentration of BSA up 
to 12% (w/v) did not effect further improvement 
(not shown). The use of acidic glycine buffer (pH 
2.5) resulted in a considerable increase (250%) in 
non-saturable binding (not shown). Therefore, 
washing with glycine buffer (pH 10.5) containing 
3% BSA was routinely used for characterization of 
T3 binding to the cells (see section 2). 
3.2. Association kinetics of T3 to hepatocytes 
at 0°C 
The time course of saturable binding to intact 
cells at 0°C was studied using the alkaline washing 
procedure. 
Fig.2 shows that residual, alkaline-resistant, 
non-saturable binding varied very little throughout 
the incubation time and was between 5 and 10% of 
TIME OF INCUBATION (Hours) 
Fig.2. Time course of association of T3 to hepatocytes at 
0°C. 4 x 10’ cells/ml were incubated with 0.1 nM 
[“‘I]T, in the absence (total, alkaline-resistant binding) 
or presence (non-saturable, alkaline-resistant binding) of 
10 pM unlabelled T3. Cells were washed by the standard 
procedure described in section 2. Each point is the mean 
of triplicates (coefficient of variation < 2%). Saturable 
binding was calculated as the difference between total 
and non-saturable binding. Non-saturable, alkaline- 
suppressible binding was calculated by subtracting 
unbound (measured as described in section 2) and 
bound, alkaline-resistant T3 from total T3 added to the 
10 20 
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Fig.3. Scatchard plot of binding of T3 to hepatocytes at 
0°C. Saturable binding was measured under the 
standard conditions described in section 2, in the 
presence and absence of 100 PM BSP. T3 concentration 
varied from 0.2 to 500 nM. Dashed lines represent he 
high-, intermediate- and low-affinity sites derived as 
cells. described in the text. 
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the total binding. Apparent equilibrium for 
saturable binding was not reached before -10 h of 
incubation. Similar slow kinetics of association of 
T3 to cultured fibroblasts at 0°C were reported by 
others [lo]. In contrast, the alkaline labile, non- 
saturable binding proceeded more rapidly, 
reaching a maximum after -5 h and slowly declin- 
ing thereafter. Non-equilibrium conditions (i.e. a 
4 h incubation) were adopted to characterize the 
binding since cell viability was not affected 
(>97%), whereas it decreased to -95% and 
85-90% after 8 and 20 h respectively, at 0°C. Fur- 
thermore, in this condition, hepatocytes remained 
able to translocate T3 to the nucleus in a manner 
similar to freshly prepared cells, when the 
temperature was raised to 25°C (not shown). 
3.3. Characteristics of T3 binding 
Fig.3 illustrates a Scatchard analysis of [“‘IIT 
binding at 0°C to isolated hepatocytes, indicative 
of either multiple categories of non-interacting 
binding sites or negative cooperativity [ 141. The ef- 
fect of BSP, a dye known to inhibit thyroid hor- 
mone binding to serum proteins [15], deiodination 
enzymes [ 161 and liver cytosol proteins [ 171, was 
examined. BSP (100 PM) partly inhibited binding 
of T3 to intact hepatocytes and increased the cur- 
vature of the Scatchard plot (fig.3). Subtraction of 
the curve obtained in the presence of BSP from 
that in its absence, along radial axes of the Scat- 
43 
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chard plot [ 14,181, yielded a straight line repre- 
senting the BSP-suppressible class of T3-binding 
sites. This was characterized by a dissociation con- 
stant (Kd) of 36 + 22 nM and a number of binding 
sites of 20 f 5 (sites x 106)/cell (mean + SD of 4 
independent determinations). The binding not sup- 
pressed by BSP could be resolved into two 
categories of binding sites by an iterative pro- 
cedure. The ‘high’- and ‘low’-affinity sites had Kd 
values of 3.5 f 1.1 and 115 + 30 nM and numbers 
of binding sites of 0.9 f 0.4 and 36 * 7 (sites 
x 106)/cell, respectively (mean f SD of 4 indepen- 
dent determinations). The three categories of 
binding sites are represented by dashed lines in 
fig.3. 
T3 binding studies conducted with liver plasma 
membrane preparations [7,8] indicated the ex- 
istence of 2 classes of binding sites: one with a Kd 
of 6-9 nM and the other with a Kd of 
220-240 nM. These values are close to those 
measured for the high- and low-affinity sites in the 
present work. Heterogeneity of binding of thyroid 
hormone to isolated liver plasma membranes was 
also suggested by photoaffinity labelling ex- 
periments [19] in which 3 distinct binding proteins 
were detected. 
The significance of the BSP inhibition of the ‘in- 
termediate’-affinity site is unknown: BSP has been 
reported to inhibit T3 and T4 uptake by rat liver in 
vivo and in vitro [20]. BSP is known to bind to the 
liver plasma membrane transporter involved in the 
hepatic uptake of bilirubin and various organic 
anions [21]. This raises the possibility that T3 could 
bind to this transporter in the plasma membrane of 
the hepatocyte. 
3.4. Specificity of hepatocyte binding sites for 
structural analogues of T3 
Competition experiments, illustrated in fig.4, 
demonstrated that T3 binding to intact hepatocytes 
at 0°C was specific. Unlabelled analogues were 
allowed to compete with [“‘IIT for binding; 
thyronine was ineffective and triac, D-T3, Tz, T4, 
r-T3 were all less effective than unlabelled T3 in 
displacing bound [12’I]T3. From the molar concen- 
tration of unlabelled iodothyronines required to 
depress the binding of tracer [“?]T3 by 50070, it
could be roughly estimated that hepatocytes bound 
TX 2.5-, 3.5-, 5-, lo- and 50-times as avidly as r-T3, 
T4, T2, D-T3 and triac, respectively. 
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Fig.4. Binding specificity of thyronine analogues. Cells 
were incubated at 0°C for 4 h with 0.2 nM [“‘I]T3 in the 
presence of increasing concentrations of unlabelled 
analogues. Saturable binding was determined as 
described in section 2 and expressed as the percentage of 
binding in the absence of unlabelled competitor. 
However, since multiple categories of binding 
sites were revealed by the Scatchard plot and since 
they all contribute to the overall binding at the 
concentration of [‘251]T3 used, this experiment 
does not detail the ipecificity of each category of 
binding site. The situation is also complicated by 
the fact that T4 and TX bind with cross-reactivity to 
separate sites in isolated liver plasma membranes 
PI. 
The fact that D-T3 has IO-times less apparent af- 
finity for hepatocytes than L-T3 indicates a high 
degree of stereospecificity. Quantitatively similar 
specificity was reported for binding of the two 
enantiomers to cultured fibroblasts [lo] and to 
purified plasma membranes from rat liver [7]. This 
can be related to the enhanced entrance of L as 
compared with D-T3 into various tissues in vivo 
[22] and into isolated hepatocytes in vitro [ 131. The 
specificity of receptors in isolated nuclei from rat 
liver is quite different: triac is 4-times as effective 
as L-T3 and D-T3 is equal to L-T3 [23]. The 
cytosol-binding protein in liver, kidney [24] and 
brain cells [25] also lacks stereospecificity towards 
L- and D-T3. 
3.5. Subcellular localization of T3 binding 
Only the intermediary, BSP-inhibited site had a 
Kd (36 nM) compatible with that of cytosol- 
binding protein [24,26]. However, the latter was 
reported to have negligible affinity for BSP [26]. 
The competition experiments indicated that 
specificity of iodothyronine binding by the whole 
hepatocyte at 0°C was different from those of the 
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nuclear receptor and cytosol-binding protein, but 
resembled those of sites in isolated plasma mem- 
brane. Negligible nuclear binding was detectable 
after a 4 h incubation of hepatocytes with T3 at 
O”C, followed by preparation of nuclei according 
to Cheng [lo] (not shown). Table 1 shows the 
distribution of saturable binding sites to 
subcellular fractions of hepatocytes after incuba- 
tion of whole cells at 0°C. Irrespective of the con- 
centration of T3 in the incubation medium, 
saturable sites were distributed equally between the 
2000 x g pellet and supernatant. A study of 
[3H]concanavalin A binding to whole hepatocytes, 
according to Record et al. [27], indicated that 
plasma membranes were present o a similar extent 
in both fractions (not shown). Further centrifuga- 
tion of the supernatant at 100000 x g for 45 min 
gave a microsomal pellet with which two thirds of 
the 2000 x g supernatant radioactivity was 
associated, the remaining third being found in the 
cytosol. However, treatment of the cytosol with 
Dowex [28] indicated that more than 90% of the 
cytosol T3 was unbound. This could originate from 
dissociation of particulate-bound T3, although 
some dissociation from cytosol-binding protein 
during the ultracentrifugation step cannot be ex- 
cluded. Therefore, after homogenization, more 
than 80% of the hepatocyte-bound T3 remained 
associated with particulate material, probably 
plasma membranes, since T3 does not enter intact 
cells at low temperature [6,9, lo]. This distribution 
is independent of the concentration of T3 over a 
wide range, indicating a similar subcellular 
localization of the various classes of saturable 
binding sites. 
In conclusion, preparation of high viability 
hepatocytes combined with alkaline washing of 
cells and partial inhibition of binding by BSP have 
permitted characterization of binding sites on 
whole cells at 0°C. These saturable sites, specific 
for T3, could be involved in entry of the hormone 
into the hepatocyte through the plasma membrane. 
Preliminary experiments indicate that part of the 
alkaline-resistant, specifically bound T3 can be 
transferred to the nucleus after subsequent incuba- 
tion of the hepatocytes at 25°C. 
About 2 x lo5 molecules of T3/cell were bound 
to saturable sites at 0°C when the free extracellular 
Ts concentration was 0.2 nM. This is -lOO-times 
more than the corresponding occupied nuclear 
sites at 37°C since, at this concentration, the 
nuclear receptors in intact hepatocytes are half- 
saturated [13]. It can be calculated that, at 0°C 
occupancy of high-, intermediate- and low-affinity 
binding sites was -5, 0.5 and 0.2070, respectively. 
Therefore, binding to these sites does not seem to 
be a limiting step for access of T3 to the cell in- 
terior. However, they might be implicated in 
stereospecific, facilitated diffusion of thyroid hor- 
mone through the cell surface. 
Table 1 
Distribution of saturable Ts binding to subcellular f actions of hepatocytes preincubated with 
various concentrations of [‘251]Tj 
T3 concentration 
0.2 nM 5nM 50 nM 200 nM 
Whole cells 0.100 (100 ) 2.46 (100 ) 18.78 (100 ) 43.52 (100 ) 
2000 x pellet g 0.045 ( 45 ) 1.14 ( 46 ) 8.89 ( 47 ) 19.11 ( 44 ) 
2000 x supernatant g 0.052 ( 52 ) 1.23 ( 50 ) 9.07 ( 48 ) 19.43 45 ) ( 
100000 X g pellet 0.033 ( 33 ) 0.81 ( 33 ) 5.95 ( 32 ) 13.01 ( 30 ) 
Cytosol 0.019 ( 19 ) 0.44 ( 18 ) 3.30 ( 18 ) 6.70 ( 15 ) 
Cytosol Dowex 0.0013 ( 1.3) 0.033 ( 1.3) 0.22 ( 1.2) 0.44 ( 1.0) 
Cells were incubated and washed as described in section 2, then Dounce-homogenized (20 
strokes) in 1 ml Hepes buffer and subcellular fractions prepared by differential 
centrifugation. Treatment of the cytosol with Dowex was according to [28]. Results are 
expressed as the number of T3 molecules (X lo-‘j bound per cell to saturable sites and are 
the mean of duplicate experiments. The percentage relative to whole cells is given in 
parentheses 
45 
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